Answers are grounded in this paper and cite their sources.
Case report explores improvement in kidney function after lymphoma treatment, suggesting cancer triggers amyloidosis.
We present a case of a 53-year-old Hispanic man with mantle cell lymphoma who developed progressive decline in estimated glomerular filtration rate despite no previous kidney disease or predisposing conditions. Findings of a renal biopsy revealed leukocyte chemotactic factor 2 (ALECT2) amyloidosis. Remarkably, after treatment of his lymphoma, the patient's estimated glomerular filtration rate normalized. Given the correlation between the patient's cancer and the improvement in kidney function after treatment, we hypothesize that his lymphoma may have acted as a trigger for ALECT2 amyloidosis through 1 or more potential mechanisms, including dysregulated Wnt/β-catenin signaling, tumor-related inflammatory pathways, or a second hit on an underlying genetic predisposition.
No takes yet. Share an insight, caveat, or question.
Ganesan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: